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tmail.comAbstract Background: Ventilation tube placement is a common surgical procedure in pediatric
otolaryngology surgery. The most common postoperative complications are otorrhea and obstruc-
tion to ventilation tube lumen. Use of topical drops after ventilation tube placement decreases the
incidence of postoperative otorrhea and the occlusion of ventilation tube.
Objective: This study carried out to evaluate the efﬁcacy of oxymetazoline solution instilled after
ventilation tube placement in prevention of postoperative otorrhea and prevention of tube occlu-
sion.
Patients and methods: Seventy-two otitis media with effusion patients whom subjected to ventila-
tion tube insertion undergoing myringotomy with ventilation tube insertion. They divided into
two groups, the right ears of all patients considered as the study group (oxymetazoline group) while
the left ears for all patients considered as the control group (saline group).
Results: Postoperative otorrhea is signiﬁcantly lower in the oxymetazoline group compared with
the saline group (5.6% and 19.4%, respectively), which was statistically signiﬁcant. In addition,
tube patency after 1 month from the operation was signiﬁcantly higher in the oxymetazoline group
compared with the saline group.Ear, Nose, Throat and Allied
evier B.V. All rights reserved.
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Chronic otitis media with effusion (OME), which usually oc-
curs as a sequel to acute otitis media or adenoid hypertrophy,
is one of the leading causes for conductive hearing loss during
childhood.1,2 Utilization of the ventilation tubes with or with-
out adenoidectomy has become the ultimate treatment of
chronic otitis media with effusion.3
Ventilation tube placement is a common surgical procedure
in pediatric otolaryngology surgery, regarded as a simple,
effective and safe.4–6 The most common postoperative compli-
cations in the ﬁrst 2 weeks are otorrhea in 13.5%, while venti-
lation tube obstruction occurred in 4%.4,5,7–9
Otorrhea usually due to the operative procedure and/or the
underlying disease process.10,11
Viscid thick secretions cause blockage of ventilation tubes
lumen or a blood clot form bleeding during the procedure,
so the tube is no longer functioning.12
To prevent such complications, sterile operative technique,
antiseptic canal preparation, middle ear irrigation, silver oxide
impregnated ventilation tube with postoperative systemic and
topical antibiotic.13 Several authors mentioned that use of top-
ical drops after ventilation tube placement decrease the inci-
dence of postoperative otorrhea and ventilation tube
occlusion.14 The role of the topical vasoconstrictor substance
drops is to decongest the mucosa of the middle ear, improve
the Eustachian tube function, and minimize the possibility of
bleeding and tube occlusion.9
This study carried out to evaluate the efﬁcacy of oxymetaz-
oline solution instilled after ventilation tube placement in pre-
vention of postoperative otorrhea and tube occlusion.
2. Patients and methods
A controlled clinical trial study was conducted in Otolaryngol-
ogy Department, Suez Canal University Hospital, Ismailia,
Egypt.
Bilateral otitis media with effusion patients subjected to
ventilation tube insertion, after failure of medical treatment,
from March 2007 to April 2009 were included to our study
while patient with previous myringotomy, tube insertion, and
unilateral otitis media with effusion or refusing the surgery
were excluded.
All patients were subjected to: full history, complete ENT
examination, pure tone audiometry, immittancemetry and lat-
eral plain X-ray for the skull, visualizing the nasopharynx.
Seventy-two patients were subjected to myringotomy with
ventilation tube insertion. Their ears were divided into two
groups: the study group (oxymetazoline ears) and the control
group (saline ears).
The right ears of all patients received oxymetazoline 0.1%
drops during the operation and three times per day for 1 week
following surgery. The oxymetazoline used is an oxymetazo-
line hydrochloride (Afrin Nasal Drops 0.1%, Schering-Plough
Health Care Products).All patients received sodium chloride 7.4 mg/ml drops in
the left ear, during the operation and three times per day for
1 week following surgery. The saline used is a sodium chloride
7.4 mg/mL (Otrivin Baby Saline Nasal Drops – Novartis).
Follow up was done for 4 weeks after surgery by otoscopic
and microscopic examination.
2.1. Statistical analysis
Data collected from the patient’s symptoms, microscopic ear
examination, intra-operative ﬁndings and postoperative com-
plication entered to soft wear SPSS (version 14).
3. Results
Bilateral otitis media with effusion patients (seventy-two) sub-
jected for bilateral ventilation tube insertion with mean age of
5.9 ± 1.85 years. 56.9% of them are males while 43.1% fe-
males. Hearing loss was the main complaint in all patients
while 16% had a history of otolagia.
All patients received amoxicillin–clavulinic acid 90 mg/kg,
oral steroids, antihistamines, nasal decongestants, and muco-
lytics for 4 weeks. Then, they were re-examined and followed
up with the tympanometry.
Tympanometry revealed a type B tympanogram in 81% of
ears and a type C tympanogram in 19% of ears.
Hearing loss in pure tone audiogram at four frequencies
(500, 1000, 2000 and 4000 Hz) showed ranges from normal
hearing to moderate conductive hearing loss (0–45 dB).
All the patients were subjected to myringotomy with pres-
sure equalization tube (PET) insertion. Additional adenoidec-
tomy was needed in 61 patients, while 7 patients underwent an
additional tonsillectomy.
The middle ear ﬂuids was mucoid in nature, in both oxy-
metazoline and saline ears (61.1% and 59.7%), serous ﬂuid
was noted in 22.2% and 26.4%, no effusion was found in
13.9% and 9.7%, respectively, while it was purulent in 2.8%
and 4.2%, respectively (Fig. 1).
Minimal intra-operative bleeding was found in both oxy-
metazoline and saline ears (68.1% and 68.1%, respectively),
no bleeding was noted in 23.6% and 20.8%, respectively, while
it was moderate in 8.3% and 11.1%, respectively.
The intra-operative bleeding considered minimal when
drops of blood are not entering the ventilation tube and mod-
erate when blood trickles in the ventilation tube or obstruct
visualization during the operation (Fig. 2).
Postoperative otorrhea signiﬁcantly decreased in the oxy-
metazoline ears compared with the saline ears (5.6% and
19.4%, respectively). The difference was statistically signiﬁcant
(Table 1).
Tube patency after 1 month from the operation was signif-
icantly better in the oxymetazoline ears compared with the sal-
ine ears (94.4% and 84.7%, respectively) (Table 1).
Postoperative tube obstruction was noted in 15 ears from
all population while it was patent in 129 ears. Mucoid middle
Figure 1 Type of middle ear effusion in both groups.
Figure 2 Amount of intra-operative bleeding in both groups.
Table 1 The postoperative otorrhea and tube obstruction.
Study ears
(n= 72)
Control ears
(n= 72)
p-Value
No. % No. %
Obstruction 4 5.6 11 15.3 0.049*
Otorrhea 4 5.6 14 19.4 0.02*
* Signiﬁcant p-value <0.05.
Table 2 The postoperative tube obstruction by middle ear
effusion and intra-operative bleeding.
Obstructed ears
(n= 15)
Patent ears
(n= 129)
p-Value
No. % No. %
Middle ear eﬀusion
Dry 4 26.6 13 10.1 0.08
Serous 1 6.7 34 26.4
Mucoid 9 60 78 60.5
Purulent 1 6.7 4 3
Intra-operative bleeding
Non 1 6.7 31 24 0.038*
Minimal 9 60 89 69
Moderate 5 33.3 9 7
* Signiﬁcant p-value <0.05.
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and 60.5%, respectively), with a statistically insigniﬁcant dif-
ference (p> 0.05). Minimal intra-operative bleeding in both
obstructed and patent ears was 60% and 69%, respectively.
Obstructed ears had a signiﬁcant higher incidence in cases with
moderate bleeding (33.3%) compared with patent ears (7%)
(Table 2).
4. Discussion
Ventilation tube insertion is one of the most common proce-
dures for otitis media with effusion.15
It serves as an artiﬁcial Eustachian tubes, thereby equaliz-
ing the middle ear pressure and allowing ﬂuid drainage.16Postoperative blockage estimated in 10% of cases causing
ineffective tube. In most instances, the blockage occurs in the
early postoperative period and may be associated with the
transient otorrhea that occurs in 16% of patients.17
Obstruction of the ventilation tubes after surgery is a frus-
trating problem, estimated to occur in 1.4–36% of cases. Most
reports found that the obstruction or blockage of the ventila-
tion tubes is due to bleeding (blood clot) during the procedure
and/or the viscid effusion material itself. Although it is a well-
described clinical problem, only a few methods described to
prevent and treat blocked tubes.15,18
Favorable anecdotal experience was achieved with the use
of topical vasoconstrictors in the prevention of ventilation
tubes obstruction and in preventing or decreasing intra-
operative bleeding. In light of this anecdotal experience, in addi-
tion to the ineffectiveness of a blocked ventilation tubes as well
as its effect on health care costs and missed work and school
days, many randomized, controlled trials designed to assess
the effectiveness of topical vasoconstrictors and antibiotics in
preventing postoperative ventilation tubes obstruction.9,13,16,19
Most of the middle ear ﬂuids were mucoid in nature in both
oxymetazoline and saline ears (61.1% and 59.7%, respec-
tively), followed by serous middle ear effusion (22.2% and
26.4%, respectively), and lastly by purulent middle ear effusion
(2.8% and 4.2%, respectively). Mucoid middle ear ﬂuids noted
in both obstructed and patent ears (60% and 60.5%, respec-
tively). Similarly, Altram et al. conducted a prospective, ran-
domized, double blind, controlled trial to determine the
efﬁcacy of phenylephrine hydrochloride in preventing ventila-
tion tube obstruction in patients undergoing myringotomy
with ventilation tube insertion. Two hundred and eight pa-
tients enrolled in his study; 157 patients (310 ears) returned
for postoperative evaluation. Myringotomy with ventilation
tube insertion performed in all ears: 139 control ears received
topical antibiotics and 171 treatment ears received topical anti-
biotics plus topical phenylephrine. The overall incidence of
ventilation tube obstruction was 5.2%: 8.6% in the control
group and 2.3% in the treatment group (p= 0.02).16
Minimal intra-operative bleeding found in both oxymetaz-
oline and saline ears (68.1% and 68.1%, respectively), while
moderate bleeding in 3.8% and 11.1%, respectively. Minimal
bleeding noted in both obstructed and patent ears (60% and
69%, respectively), postoperative otorrhea is signiﬁcantly
decreased in the studied ears compared with the control ears
(5.6% and 19.4%, respectively) (p< 0.05). Signiﬁcant
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ied ears is due to the nature of topical oxymetazoline.
In agreement with our results, Jamal, conducted a study to
assess the effect of using a vasoconstrictor solution to cover the
tympanic membrane after ventilation tube insertion to ensure
hemostasis in the immediate postoperative period and to
decongest the mucosa of the middle ear and the Eustachian
tube. Xylometazoline hydrochloride (Otrivin Nasal Drops
0.1% or Pediatric Nasal Drops 0.05%) introduced into 60 ears
in 32 patients undergoing myringotomy and ventilation tube
insertion. The control group, consisting of 76 ears in 40 pa-
tients, underwent only myringotomy and ventilation tube
insertion. In a follow-up period of 3 months, postoperative
tube obstruction occurred in 10.5% of the patients in the con-
trol group. No case of blocked tube occurred in the patients
who received xylometazoline.19
Multivariante analysis performed by Altman et al. They
found similar results as ours suggesting that the use of phenyl-
ephrine signiﬁcantly reduces the amount of bleeding and
obstruction to which it is related. The test for bleeding showed
that there was increased odds of blockage with an increased
amount of bleeding (p= 0.05).16
Ramadan et al. performed a 1-year prospective study, 60
patients with chronic serous otitis media underwent bilateral
tympanocentesis with tube insertion. The right ear was treated
with dexapolyspectran (a solution consisting of polymyxin B
sulfate, neomycin sulfate, sulfonamide and hydrocortisone)
intra-operatively. Five (8.3%) out of 60 experimental ears
had purulent otorrhea within the ﬁrst 14 days after surgery,
compared with eight (13.3%) out of 60 control ears. Statistical
analysis showed no signiﬁcant difference between the two
groups.20
Pearson et al. carried out a prospective randomized con-
trolled study to investigate the effect of prophylactic antibiotic
ear drops used for 5 days after bilateral grommet insertion.
The drops had no signiﬁcant effect upon grommet function
at 3 months measured by blockage rates, extrusion rates or
improvement in pure tone audiometry whether or not there
was an effusion. The drops were not therefore cost-effective.21
Arya et al. compared antibiotic/steroid therapy with no
treatment in a randomized, double-blind study of blockage
in 61 patients undergoing bilateral grommet insertion. The
incidence of tube obstruction in ears treated with dexametha-
sone 0.05%/framycetin 0.5%/gramicidin 0.005% was 1.6%,
compared with 13.1% for the untreated ears (p= 0.05). The
authors did not ﬁnd any association between tube blockage
and either per operative bleeding or the nature and presence
of middle ear secretions.22
Elden et al. in the previous survey found that 80% of
respondents always place eardrops at the time of surgery. Ele-
ven percent of respondents apply drops only when discharge is
present and 7% only when thick mucus or blood is present.
Two percent of respondents never administer drops. The most
commonly used drops contain antibiotic alone (56%) or a
combination of antibiotic/steroids (35%). Thirteen percent ap-
ply decongestant drops containing oxymetazoline or xylomet-
azoline. Nearly all (94%) of the physicians instruct their
patients to use ear drops postoperatively two to three times
per day for a range of 2–7 days.15 Finally, Elden et al. con-
ducted a survey that estimates the clinical impact of blocked
tubes in children. They found that one hundred and twenty-
two members have responded (58%). Most clinicians saw theirpatients 4–8 weeks after surgery. The estimated blockage rate
was between 0% and 9% (despite the use of prophylactic drops
applied preoperatively including those with antibiotics only
(55%), antibiotic with steroids (36%) or decongestant drops
(14%), respectively).155. Conclusion
Utilization of oxymetazoline solution after ventilation tube
insertion signiﬁcantly reduces the postoperative otorrhea and
tube occlusion giving the tube a perfect function.References
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